Arvinas Stock News & Updates
[WKN: A2N6VP | Symbol: ARVN]
Arvinas (ARVN) in our Pivotal Point Check: Groundbreaking PROTAC Drugs and Analyst Upgrade Drive the Biotech Company up Over 20% after Quarterly Results!
Arvinas is developing a new class of drugs called PROTAC to selectively degrade disease-causing proteins....
Arvinas: Barclays Sees 110% Price Potential - Experts see Multiple Opportunities in Oncology and Neurology
Arvinas Inc. (ARVN) is a biotechnology company developing a unique technology called PROTACs (PROteolysis...
- ‹
- 1
- ›